Status:
RECRUITING
PRO for Fighting FT in Ovarian Cancer
Lead Sponsor:
National Cancer Institute, Naples
Conditions:
Ovarian Cancer
Eligibility:
FEMALE
Brief Summary
Non-profit, multicenter, prospective, observational study. This study aims to evaluate whether the articulated treatment algorithm that is now possible for OC patients does produce tangible changes of...
Detailed Description
PROFFIT questionnaire is an Italian instrument for evaluating FT in cancer patients in the Italian healthcare context. It includes 16 total items, 7 measuring FT (defining the PROFFIT financial score)...
Eligibility Criteria
Inclusion
- Written informed consent provided;
- Women ≥18 years;
- Histologically or citologically confirmed diagnosis of epithelial ovarian, fallopian tube or peritoneal cancer stage IC-IV according to FIGO staging system;
- Patients who are close to begin any type of medical treatment against ovarian cancer.
Exclusion
- Major cognitive dysfunction or psychiatric disorders;
- Patients with epithelial ovarian, fallopian tube or peritoneal cancer candidate exclusively to follow-up;
- Patients who have received more than 4 previous lines of medical treatment (maintenance treatments do not represent a line).
Key Trial Info
Start Date :
October 30 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2027
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT06032975
Start Date
October 30 2023
End Date
September 1 2027
Last Update
November 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nation Cancer Institute of Naples, Division of Medical Oncology - Uro-Gynecology Department
Naples, Italy